- Home
- Products
- Customized FluoroAb™
- CCL2
- Anti-CCL2 MAb (Clone 2)-iFluor® 532 Succinimidyl Ester
Anti-CCL2 MAb (Clone 2)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13138)
This product is comprised of an Human Anti-CCL2 IgG1-kappa antibody (Clone 2) labeled with iFluor® 532 Succinimidyl Ester. iFluor® 532 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- CCL2
- Alternative Names
- CCL2; chemokine (C-C motif) ligand 2; SCYA2; small inducible cytokine A2 (monocyte chemotactic protein 1; homologous to mouse Sig je); C-C motif chemokine 2; GDCF 2; HC11; MCAF; MCP 1; MCP1; MGC9434; monocyte chemoattractant protein 1; monocyte chemotactic and activating factor; monocyte chemotactic protein 1; homologous to mouse Sig je; monocyte secretory protein JE; small inducible cytokine subfamily A (Cys Cys); member 2; SMC CF; small-inducible cytokine A2; monocyte chemoattractant protein-1; small inducible cytokine subfamily A (Cys-Cys); member 2; small inducible cytokine A2 (monocyte chemotactic protein 1; homologous to mouse Sig-je); MCP-1; SCYA2; GDCF-2; SMC-CF; HSMCR30;
- Overview
- This gene is one of several cytokine genes clustered on the q-arm of chromosome 17. Chemokines are a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of N-terminal cysteine residues of the mature peptide. This chemokine is a member of the CC subfamily which is characterized by two adjacent cysteine residues. This cytokine displays chemotactic activity for monocytes and basophils but not for neutrophils or eosinophils. It has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis and atherosclerosis. It binds to chemokine receptors CCR2 and CCR4.
- Overview
- Human Anti-CCL2 IgG1-kappa antibody (Clone 2)
- Species Reactivity
- Human
- Name
- iFluor® 532 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 537/560
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS13138. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-756 | Anti-CCL2 (Carlumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-754 | Anti-CCL2 (Carlumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-757 | Anti-CCL2 (Carlumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-753 | Anti-CCL2 (Carlumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-752 | Anti-CCL2 (Carlumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-TPBG MAb (Clone 8)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11103)
- Anti-FOLR1 MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3505)
- Anti-TNFRSF17 MAb (Clone 10)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8069)
- Anti-TNFRSF17 MAb (Clone 24)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16327)
- Anti-MST1R MAb (Clone 5)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7174)
- Anti-Rabies Virus Glycoprotein MAb (Clone 4)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS12322)
- Anti-CD33 MAb (Clone 6)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12770)
- Anti-AOC3 MAb (Clone 5)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14922)
- Necitumumab-iFluor 680 (CAT#: ADC-FL-1198)
- Anti-CSF1R MAb (Clone 3)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10872)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
